Efficacy and safety of imeglimin in combination with insulin in Japanese patients with type 2 diabetes: results of TIMES 3 trial

被引：0
|
作者：
Dubourg, J. [1 ]
Watada, H. [2 ]
Thang, C. [1 ]
Kaneko, T. [3 ]
Fouqueray, P. [1 ]
机构：
[1] Poxel SA, Lyon, France
[2] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan
[3] Poxel SA, Tokyo, Japan
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
637
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of Imeglimin for Type 2 Diabetes in Patients Undergoing Dialysis
    Mima, Akira
    IN VIVO, 2023, 37 (03): : 1334 - 1338
  • [2] Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week, open-label, multicentre phase 3 trial
    Dubourg, Julie
    Fouqueray, Pascale
    Quinslot, Damien
    Grouin, Jean-Marie
    Kaku, Kohei
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 609 - 619
  • [3] Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
    Sato, Seiji
    Saisho, Yoshifumi
    Kou, Kinsei
    Meguro, Shu
    Tanaka, Masami
    Irie, Junichiro
    Kawai, Toshihide
    Itoh, Hiroshi
    PLOS ONE, 2015, 10 (03):
  • [4] Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study
    Kaku, Kohei
    Kuroda, Shingo
    Ishida, Kazuyuki
    Umeda, Yuusuke
    DIABETES OBESITY & METABOLISM, 2018, 20 (10): : 2490 - 2493
  • [5] Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
    Inagaki, Nobuya
    Harashima, Shin-ichi
    Kaku, Kohei
    Kondo, Kazuoki
    Maruyama, Nobuko
    Otsuka, Makiko
    Kawaguchi, Yutaka
    Iijima, Hiroaki
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 812 - 820
  • [6] Efficacy and Safety of Saxagliptin in Combination With Insulin in Elderly Patients With Type 2 Diabetes
    Charbonnel, Bernard
    Barnett, Anthony H.
    Monyak, John
    Minervini, Gianmaria
    Iqbal, Nayyar
    DIABETES, 2012, 61 : A269 - A269
  • [7] Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
    Kubota, Akira
    Maeda, Hajime
    Kanamori, Akira
    Matoba, Kiyokazu
    Jin, Yasuyuki
    Minagawa, Fuyuki
    Obana, Mitsuo
    Iemitsu, Kotaro
    Ito, Shogo
    Amamiya, Hikaru
    Kaneshiro, Mizuki
    Takai, Masahiko
    Kaneshige, Hideaki
    Hoshino, Kazuhiko
    Ishikawa, Masashi
    Minami, Nobuaki
    Takuma, Tetsuro
    Sasai, Nobuo
    Aoyagi, Sachio
    Kawata, Takehiro
    Mokubo, Atsuko
    Takeda, Hiroshi
    Honda, Shin
    Machimura, Hideo
    Motomiya, Tetsuya
    Waseda, Manabu
    Naka, Yoshikazu
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 503 - 509
  • [8] Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
    Kadowaki, Takashi
    Kondo, Kazuoki
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (06) : 576 - 584
  • [9] Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period
    Reilhac, Caroline
    Dubourg, Julie
    Thang, Carole
    Grouin, Jean-Marie
    Fouqueray, Pascale
    Watada, Hirotaka
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 838 - 848
  • [10] Long-termefficacy and safety of canagliflozin in combination with insulin in Japanese type 2 diabetes patients
    Harashima, S.
    Inagaki, N.
    Kaku, K.
    Kondo, K.
    Maruyama, N.
    Otsuka, M.
    Kawaguchi, Y.
    Watanabe, Y.
    Goda, M.
    Iijima, H.
    DIABETOLOGIA, 2017, 60 : S20 - S20
12345